Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-aminobutyric acid receptor subunit alpha-6 (GABRA6) is a protein that forms part of the GABA-A receptor, a ligand-gated chloride channel and one of the primary mediators of inhibitory neurotransmission in the mammalian central nervous system. α6-containing GABA-A receptors are essential for precise timing in motor activity and are implicated in neuropsychiatric disorders and other neurological conditions. Drugs targeting this specific subtype may offer new avenues for treating certain movement disorders or psychiatric conditions.
Allosteric modulation of chloride conductance
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit alpha-6 (GABRA6).